Induction therapy by frequent administration of doxorubicin with four other drugs, followed by inten...
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
About this item
Full title
Author / Creator
TAKEUCHI, J , KYO, T , ASOU, N , INO, T , OKAMOTO, T , USUI, N , NISHIMURA, M , SHINAGAWA, K , FUKUSHIMA, T , TAGUCHI, H , MORII, T , MIZUTA, S , NAITO, K , AKIYAMA, H , NAKAMURA, Y , OHSHIMA, T , OHNO, R , SAO, H , TAKAHASHI, M , MIYAWAKI, S , KURIYAMA, K , OHTAKE, S , YAGASAKI, F and MURAKAMI, H
Publisher
London: Nature Publishing
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing
Subjects
More information
Scope and Contents
Contents
In order to improve the disappointing prognosis of adult patients with acute lymphoblastic leukemia (ALL), we applied similar induction therapy as that used for acute myeloid leukemia (AML), ie frequent administration of doxorubicin (DOX). DOX 30 mg/m(2) was administered from days 1 to 3 and from days 8 to 10 together with vincristine, prednisolone...
Alternative Titles
Full title
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_817604014
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_817604014
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/sj.leu.2402526
